RESUMEN
In the United States, alcohol is the most common substance used and the spectrum of unhealthy alcohol use is highly prevalent. Complications of unhealthy alcohol use affect nearly every organ system. One of the most frequent and potentially life-threatening of these complications is alcohol withdrawal syndrome for which benzodiazepines remain first-line therapy. Pharmacologic treatment of alcohol use disorder, the most severe form of unhealthy alcohol use, is underutilized despite the availability of multiple effective medications. Although behavioral therapies are an important component of treatment, they are overemphasized at the expense of pharmacotherapy.
Asunto(s)
Alcoholismo/diagnóstico , Alcoholismo/terapia , Benzodiazepinas/uso terapéutico , Terapia Cognitivo-Conductual/métodos , Síndrome de Abstinencia a Sustancias/tratamiento farmacológico , Anciano , Síndrome Alcohólico de Korsakoff/diagnóstico , Síndrome Alcohólico de Korsakoff/epidemiología , Alcoholismo/complicaciones , Alcoholismo/epidemiología , Biomarcadores/sangre , Nivel de Alcohol en Sangre , Quimioterapia/economía , Femenino , Humanos , Hepatopatías Alcohólicas/diagnóstico , Hepatopatías Alcohólicas/epidemiología , Masculino , Síndrome de Abstinencia a Sustancias/etiología , Estados UnidosRESUMEN
Performance validity tests (PVTs) and Symptom validity tests (SVTs) are developed to identify people that present false or exaggerated symptoms. Although a key factor of both types of tests includes relative insensitivity to cognitive disorders, the direct effects of amnesia have been poorly studied. Therefore, a sample of 20 patients diagnosed with Korsakoff Amnesia (KA) through neuropsychological assessment and 20 healthy comparisons (HC) were administered the Test of Memory Malingering (TOMM), the Structured Inventory of Malingered Symptomatology (SIMS), and the newly developed Visual Association Test - Extended (VAT-E). Our results show that KA patients scored systematically lower on the TOMM and VAT-E, while performance on the SIMS was comparable with healthy comparisons. Some KA patients were regarded as underperformers based on the TOMM and VAT-E, suggesting limitations in applying these instruments in severe amnesia. There was a strong interdependence of PVTs in logistic regression. We conclude that the TOMM and VAT-E are not fully robust against severe memory disorders and show a serious risk of false positives. Complete neuropsychological profile analysis is needed, and PVTs should be interpreted with caution in patients with suspected amnesia.
Asunto(s)
Síndrome Alcohólico de Korsakoff/diagnóstico , Simulación de Enfermedad/diagnóstico , Anciano , Síndrome Alcohólico de Korsakoff/fisiopatología , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Pruebas de Memoria y Aprendizaje , Persona de Mediana Edad , Pruebas Neuropsicológicas , Reproducibilidad de los ResultadosRESUMEN
BACKGROUND: Wernicke-Korsakoff Syndrome (WKS) resulting from thiamine deficiency is classically defined as including encephalopathy, ataxia, and ophthalmoplegia. Only 16% of autopsy-confirmed patients with WKS exhibit all three signs. Caine-positive WKS criteria include two or more of the following: nutritional deficiency, delirium or mild memory impairment, cerebellar dysfunction/ataxia, and oculomotor abnormalities. OBJECTIVE: We describe Caine-positive WKS prevalence among psychiatric inpatients and compare pretreatment-versus-posttreatment neurocognitive improvement to an unaffected group. METHODS: This 6-month quality-improvement evaluation included two-stage screening for Caine-positive WKS, administering high-dose intravenous thiamine (day 1: 1200 mg; days 2-4: 200 mg) with reexamination on day 5. We used descriptive statistics and fitted random effects models to examine rate-of-change differences in pre-/posttreatment Montreal Cognitive Assessment (MoCA), delayed 5-item recall, and gait/coordination scores between treated Caine-positive patients with WKS and untreated Caine-negative patients. RESULTS: Of 262 patients, 32 (12%) had Caine-positive WKS; 17 (53%) used alcohol currently. Treated Caine-positive WKS (n = 26) versus Caine-negative comparison (n = 34) before and after treatment observed a mean change (standard deviation) in the MoCA score of 3.6 (2.5) versus 1.8 (2.5) (P < 0.01); 5-item recall: 1.8 (1.4) versus 0.5 (1.4) (P < 0.001); gait/coordination scores: -0.6 (1.2) versus -0.1 (0.6) (P < 0.001). Oculomotor abnormalities were infrequent (n = 4 in Caine-positive WKS, n = 2 in Caine-negative comparison groups). CONCLUSIONS: Caine-positive WKS prevalence among psychiatric inpatients was 12%; only half used alcohol. Patients treated with high-dose thiamine demonstrated clinically significant neurocognitive improvement.
Asunto(s)
Ataxia/fisiopatología , Encefalopatías/fisiopatología , Síndrome de Korsakoff/epidemiología , Oftalmoplejía/fisiopatología , Adulto , Síndrome Alcohólico de Korsakoff/diagnóstico , Síndrome Alcohólico de Korsakoff/tratamiento farmacológico , Síndrome Alcohólico de Korsakoff/epidemiología , Síndrome Alcohólico de Korsakoff/fisiopatología , Enfermedades Cerebelosas/fisiopatología , Delirio/fisiopatología , Femenino , Hospitalización , Humanos , Síndrome de Korsakoff/diagnóstico , Síndrome de Korsakoff/tratamiento farmacológico , Síndrome de Korsakoff/fisiopatología , Masculino , Desnutrición/epidemiología , Tamizaje Masivo , Trastornos de la Memoria/fisiopatología , Pruebas de Estado Mental y Demencia , Persona de Mediana Edad , Trastornos de la Motilidad Ocular/fisiopatología , Prevalencia , Tiamina/uso terapéutico , Deficiencia de Tiamina/tratamiento farmacológico , Deficiencia de Tiamina/fisiopatología , Delgadez/epidemiología , Resultado del Tratamiento , Complejo Vitamínico B/uso terapéutico , Pérdida de PesoRESUMEN
Regular heavy consumption of alcohol is associated with a wide range of physical, psychological and social problems. All health-care clinicians should be able to screen for and detect problematic levels of alcohol consumption in their patients, and deliver an effective brief intervention. When patients with alcohol dependence are admitted to hospital there must be an assessment of whether medication is required to prevent withdrawal symptoms and potential delirium tremens and withdrawal seizures. Medically assisted alcohol withdrawal using a long-acting benzodiazepine such as chlordiazepoxide should be carefully monitored and titrated to effect, and the clinician should be aware of the risk of Wernicke-Korsakoff syndrome and other complications. Abstinence from alcohol is usually only the first step in treatment, and effective linkage to community alcohol services is an important step.
Asunto(s)
Delirio por Abstinencia Alcohólica/prevención & control , Convulsiones por Abstinencia de Alcohol/prevención & control , Alcoholismo/diagnóstico , Benzodiazepinas/uso terapéutico , Delirio por Abstinencia Alcohólica/etiología , Convulsiones por Abstinencia de Alcohol/etiología , Síndrome Alcohólico de Korsakoff/diagnóstico , Síndrome Alcohólico de Korsakoff/etiología , Síndrome Alcohólico de Korsakoff/prevención & control , Síndrome Alcohólico de Korsakoff/terapia , Alcoholismo/complicaciones , Alcoholismo/terapia , Servicios Comunitarios de Salud Mental , Hospitalización , Humanos , Derivación y Consulta , Medición de Riesgo , Encefalopatía de Wernicke/diagnóstico , Encefalopatía de Wernicke/etiología , Encefalopatía de Wernicke/prevención & control , Encefalopatía de Wernicke/terapiaRESUMEN
AIM: In the last years with the increase of bariatric surgery, first of all as a result of new indications, a rise in the incidence of nutrient-related complications has been observed. Currently little is known about the impact of post-bariatric malnutrition and neurological complications. Wernicke's encephalopathy is a severe neurological syndrome which occurs as a result of thiamine deficiency. Wernicke-Korsakoff syndrome must be considered a serious neurological complication of bariatric surgery with significant morbidity and mortality, with rapidly progressing neurological symptoms, and must be treated immediately. CASE REPORT: We report the case of a 35 years-old male patient, affected by morbid obesity, anxious-depressive syndrome and alcohol use disorder, who after adjustable gastric banding implanted in another hospital developed a severe malnutrition and neurological syndrome. The patient showed poor adherence to the follow-up and to the dietary indications and after all, we needed to place a PEG for enteral nutrition in order to resolve the malnutrition condition and the neurological syndrome. Our experience emphasizes that preoperative selection and assessment of a patient's nutritional status according to guidelines, is required to identify potential problems, and that bariatric surgeons or physicians caring for patient who have undergone bariatric surgery should be familiar with the constellation of nutritional and neurological disorder that may occur after surgery. CONCLUSION: We want to remark the importance of preoperative selection of the patients, the follow-up and the cooperation between patient and physician in order to obtain the best result and avoid severe complications.
Asunto(s)
Gastroplastia/efectos adversos , Síndromes de Malabsorción/etiología , Complicaciones Posoperatorias/etiología , Encefalopatía de Wernicke/etiología , Adulto , Síndrome Alcohólico de Korsakoff/diagnóstico , Trastornos de Deglución/etiología , Diagnóstico Diferencial , Nutrición Enteral , Motilidad Gastrointestinal , Humanos , Síndromes de Malabsorción/metabolismo , Síndromes de Malabsorción/terapia , Masculino , Cooperación del Paciente , Complicaciones Posoperatorias/metabolismo , Complicaciones Posoperatorias/terapia , Náusea y Vómito Posoperatorios/complicaciones , Tiamina/farmacocinética , Deficiencia de Vitamina B 12/etiología , Deficiencia de Vitamina B 12/psicología , Deficiencia de Vitamina B 12/terapia , Encefalopatía de Wernicke/diagnósticoRESUMEN
Alcohol-related dementia represents an underrecognised mental disorder with both clinical and public mental health aspects. There is considerable scope for improving its assessment within both mainstream and specialist mental health services, but ongoing challenges remain in ensuring its timely detection so that appropriate preventative and rehabilitative interventions can be applied. Declaration of interest None.
Asunto(s)
Trastornos Relacionados con Alcohol , Demencia , Trastornos Relacionados con Alcohol/diagnóstico , Trastornos Relacionados con Alcohol/epidemiología , Trastornos Relacionados con Alcohol/fisiopatología , Síndrome Alcohólico de Korsakoff/diagnóstico , Síndrome Alcohólico de Korsakoff/epidemiología , Síndrome Alcohólico de Korsakoff/fisiopatología , Demencia/inducido químicamente , Demencia/diagnóstico , Demencia/epidemiología , Demencia/fisiopatología , HumanosRESUMEN
AIMS: To characterize a series of contemporary patients with alcohol-related Wernicke's encephalopathy (WE) or Korsakoff's syndrome (KS) and to update the current prognosis of disease. METHODS: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or KS between 2002 and 2011 in a tertiary hospital. Socio-demographic, alcohol use characteristics, signs and symptoms, co-morbidity and blood parameters were obtained at admission. Patients were followed up until 2013 and causes of death were ascertained through the review of charts. RESULTS: Sixty-one patients were included (51 with WE and 10 with KS). Among patients with WE, 78% were men and age at diagnosis was 57 years (interquartile range (IQR): 49-66). Twenty-three percent fulfilled the classic WE triad. Regarding Caine's criteria for WE, 70.6% presented with at least two out of four signs or symptoms. Median follow-up of patients with WE syndrome was 5.3 years (IQR: 2.6-8.8), the cumulated mortality was 45% and death rate of 7.4 × 100 person-years (95% confidence interval (CI): 4.8-10.9). Overall, 50% of patients would be expected to die within 8 years of WE episode and main causes of death included serious bacterial infections (44.5%) and cancer (33.3%). CONCLUSIONS: Survival of patients with an alcohol-related Wernicke-Korsakoff syndrome is poor; pursuing treatment of alcohol use disorder and early diagnosis of thiamine deficiency is a priority for improving clinical outcomes.